BioMarin Pharmaceutical Inc (NASDAQ:BMRN) Risk Hits A Deteriorated LevelDate Published: 2017-11-23
Risk Malaise Alert -- Not How You Might Think:
Before we dive into any analysis we simply note that BioMarin Pharmaceutical Inc (NASDAQ:BMRN) risk is actually priced pretty low by the option market as of right now. We'll detail it below -- but that's the lede -- the option market is reflecting a sort of risk malaise, for now, an IV30 of 30.23% versus the IV30 of the S&P 500 at 7.48%. The annual high for BioMarin Pharmaceutical Inc IV30 is 48.95% -- and we're below that level. The alert here is low vol.
One thing to note beyond the risk malaise alert, which we cover in the article, is that while implied volatility may be low, the real question that needs to be answered for option sellers is not if the implied vol is low, but rather if the realized volatility that is coming in the next 30 days will be lower than the option market is pricing.
To skip ahead of this risk alert and see if buying or selling options has been a winner in BioMarin Pharmaceutical Inc, you can go here: Getting serious about option trading.
This is a proprietary risk rating and risk alert system that looks forward for the next month -- or really 30 days to be exact -- and that includes weekends. The system is based on multiple interactions of data points, many of which come directly from the option market for BioMarin Pharmaceutical Inc (NASDAQ:BMRN) . The creator of this model is Capital Market Laboratories (CMLviz.com).
In the "Why This Matters" section at the end of this article on BioMarin Pharmaceutical Inc we're going to take a step back and show in great specificity that there is actually a lot less "luck" in successful option trading than many people know. The whole concept of an "option trading expert" is vastly over complicated and we'll talk about how superior returns are earned.
But first, let's turn back to BMRN and the company's risk rating:
We also take a peek at the implied vol for the Health Care ETF (XLV), our broad based proxy for BMRN.
|S&P 500 IV30||7.48%|
|Nasdaq 100 IV30||11.13%|
|BMRN HV 30||22.43%|
|BMRN Current IV30||30.23%|
|52 Week Low IV30||27.77%|
|52 Week High IV30||48.95%|
The risk as reflected by the option market has hit a deteriorated level relative to the company's past. The option market reflects a 95% confidence interval stock price range of ($77.30, $88.70) within the next 30 calendar days.
While the option market risk rating is on the low side, we note that companies in this situation are still susceptible to sudden stock move risk, it's simply the probability of that large stock move is depressed. Buyers of options and volatility may find these prices more attractive than at other times.
BMRN OPTION MARKET RISK
The IV30® is the risk reflected by the option market in the stock price for the next 30 calendar days -- it's forward looking. BioMarin Pharmaceutical Inc shows an IV30 of 30.2%, which is a deteriorated level for the company relative to its past.
The option market for BMRN has shown an IV30 annual low of 27.8% and an annual high of 49.0%, meaning that BMRN is at the 12% percentile right now. Here's a table of the data before we dig into the risk rating further.
The implied stock swing risk from the option market is significantly tighter in the next 30 calendar days for BioMarin Pharmaceutical Inc (NASDAQ:BMRN) than it has been on average for the year.
We have an unusual situation now where the IV30 is substantially depressed relative to the past, but even with that risk pricing, the option market reflects the likelihood of more stock movement in the next 30-days than it has in the last 30-days. Let's turn to a chart to see what's going on.
BioMarin Pharmaceutical Inc Risk Rating
The BMRN risk rating is at 2, where the rating goes from one (the lowest risk) to five (the highest risk). The driving factors for the 2 rating are:
↪ The IV30 is below the 20th percentile.
↪ The HV30 is below the annual average.
↪ The HV30 is below 30%.
↪ The IV30 is above the HV30.
↪ The stock has moved just +2.0% over the last 3-months which does indicate some depressed risk.